News
A POPULAR nerve and back pain medicine has been linked to an increased risk of dementia by scientists. The risk was ...
14h
Best Life on MSNResearchers Warn This Common Pain Med Could Increase Dementia Risk by 29%Researchers found that the pain drug gabapentin can increase the risk of dementia by 29% and mild cognitive impairment by 85%.
These medications could give you dementia if you take them too often — two are over-the-counter By . Tracy Swartz. Published Dec. 13, 2024, 6:14 p.m. ET. This could be a hard pill to swallow.
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
6d
healthdigest.com on MSNPopular Anxiety Medications That Could Increase Your Risk Of DementiaFor some people, taking anxiety medications is the best way to help them keep functioning throughout the day. But how can ...
Using brain imaging techniques, researchers found reduced brain sizes and lower metabolism in older patients taking drugs that are commonly used to help people fall asleep or fight allergies.
View list of generic and brand names of drugs used for treatment of Vascular Dementia. Find more information including dose, side effects of the Vascular Dementia medicine.
This story was updated on July 25, 2023, to correct when the U.S. Food and Drug Administration approved the Alzheimer's drug aducanumab (brand name Aduhelm). The drug was approved in 2021, not in ...
Meanwhile, an analysis of 26 trials — with a total of 164,531 participants — also published in JAMA Neurology today had similar findings, linking GLP-1 drugs to a 45% lower risk of dementia.
It’s possible, but not proven, that some anticholinergic drugs increase the risk of dementia. If you need long-term treatment for one of the relevant medical conditions, ...
Drugs often used to treat elderly patients with dementia-related aggression and delusions can raise their risk of death, according to a study that reinforces new warning labels required on the ...
The Food and Drug Administration may soon grant full approval to an Alzheimer's drug. When it does, Medicare will start more widely covering the costly drug — but hurdles to access remain.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results